US Drug Recall Register
Class III · Low risk Terminated Initiated Mar 15, 2013 (13 years ago)

Camila

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing

What was recalled

Camila (norethindrone tablets, USP), 0.35 mg, 6 blister cards per carton, 28 tablets each, 28 day regimen, Rx Only, Teva Pharmaceuticals USA, Sellersville, PA 18960, NDC 0555-0715-58

Recalling firm
Teva Pharmaceuticals USA, Inc.
NDC code
0555-0715-58
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-690-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Norethindrone recalls

See all
Class II · Moderate risk Ongoing

Alyacen 7/7/7

Reason Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.

Glenmark Pharmaceuticals Inc., USA NDC 68462-556-29 D-0588-2026
Class III · Low risk Ongoing

Nortrel 7/7/7

Reason Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.

Teva Pharmaceuticals USA, Inc NDC 0555-9012-58 D-0322-2024
Class III · Low risk Ongoing

Nortrel

Reason Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.

Teva Pharmaceuticals USA, Inc NDC 0555-9008-67 D-0321-2024
Class III · Low risk Terminated

Mimvey

Reason Mislabeling

Teva Pharmaceuticals USA NDC 0093-5455-42 D-0522-2022
Class III · Low risk Terminated

Mimvey

Reason Mislabeling

Teva Pharmaceuticals USA NDC 0093-5455-28 D-0521-2022